Sarepta Therapeutics to Present Company Overview at Upcoming Conferences

Barclay’s Global Healthcare Conference 2015
Cowen Health Care Conference 2015
ROTH Conference 2015

CAMBRIDGE, Mass.--()--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-based therapeutics, today announced that management is scheduled to present a company overview at the following investor conferences in March. Chris Garabedian, Sarepta’s president and chief executive officer, will be the presenter.

  • Cowen and Company 35th Annual Health Care Conference in Boston, MA on Monday, March 2 at 4:10 p.m. EST.
  • 27th Annual ROTH Conference in Dana Point, CA on Monday, March 9 at 3:00 p.m. PST.
  • Barclays Global Healthcare Conference 2015 in Miami Beach, FL on Thursday, March 12 at 1:35 p.m. EST.

The presentations will be webcast live on the investor relations section of the Sarepta Therapeutics website at www.sarepta.com and will be archived under the events and presentations section following each presentation for 90 days.

About Sarepta Therapeutics
Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy, as well as potential treatments for some of the world's most lethal infectious diseases. Sarepta aims to build a leading, independent biotech company dedicated to translating its RNA-based science into transformational therapeutics for patients who face significant unmet medical needs. For more information, please visit us at www.sarepta.com.

Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our web site at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Contacts

Media and Investors:
Sarepta Therapeutics, Inc.
Ian Estepan, 617-274-4052
iestepan@sarepta.com

Contacts

Media and Investors:
Sarepta Therapeutics, Inc.
Ian Estepan, 617-274-4052
iestepan@sarepta.com